Lyoniresinol inhibits melanogenic activity through the induction of microphthalmia-associated transcription factor and extracellular receptor kinase activation

Molecular and Cellular Biochemistry

Volumn 373, Issue 1-2, 2013, Pages 211-216

  Liu, Huiyu ^a   Sui, Xiaoxin ^b   Li, Xiaohong ^c   Li, Yuzhen ^d  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Dermatology Department   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

(+) Lyoniresinol; Akt; ERK; Lignans; Melanogenesis; MITF; Tyrosinase

Indexed keywords

CELL RECEPTOR; DEPIGMENTING AGENT; LYONIRESINOL; MELANIN; METHANOL; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TYROSINASE RELATED PROTEIN 1; UNCLASSIFIED DRUG; VITEX NEGUNDO EXTRACT;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CANCER CELL; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; MELANOGENESIS; MOUSE; NONHUMAN; PLANT ROOT; PROTEIN PHOSPHORYLATION; PURIFICATION; STEADY STATE; VITEX NEGUNDO;

ANIMALS; ANISOLES; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTERFERON TYPE I; INTRAMOLECULAR OXIDOREDUCTASES; MAP KINASE SIGNALING SYSTEM; MELANINS; MELANOMA, EXPERIMENTAL; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; NAPHTHALENES; PHOSPHORYLATION; PREGNANCY PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SKIN LIGHTENING PREPARATIONS; TRANSCRIPTIONAL ACTIVATION;

MURINAE; VITEX NEGUNDO;

EID: 84871776724     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1492-7     Document Type: Article

References (23)

1. Hearing VJ (2005) Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J Dermatol Sci 37:3-14
2. Seiberg M, Paine C, Sharlow E, Andrade-Gordon P, Costanzo M, Eisinger M, Shapiro SS (2000) Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 115:162-167
3. Chang TS (2009) An updated review of tyrosinase inhibitors. Int J Mol Sci 10:2440-2475
4. Ito S, Wakamatsu K (2008) Chemistry of mixed melanogenesis-pivotal roles of dopaquinone. Photochem Photobiol 84:582-592
5. Yamaguchi Y, Hearing VJ (2009) Physiological factors that regulate skin pigmentation. BioFactors 35:193-199
6. Kim YJ, Uyama H (2005) Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future. Cell Mol Life Sci 62:1707-1723
7. Nakagawa M, Kawai K, Kawai K (1995) Contact allergy to kojic acid in skin care products. Contact Dermat 32:9-13
8. Bentley NJ, Eisen T, Goding CR (1994) Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol 14:7996-8006
9. Buscà R, Ballotti R (2000) Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13:60-69
10. Price ER, Horstmann MA, Wells AG, Weilbaecher KN, Takemoto CM, Landis MW, Fisher DE (1998) Alpha-melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem 273:33042-33047
11. Tachibana M (1997) Evidence to suggest that expression of MITF induces melanocyte differentiation and haploinsufficiency of MITF causes Waardenburg syndrome type 2A. Pigment Cell Res 10:25-33
12. Jiang Z, Xu J, Long M, Tu Z, Yang G, He G (2009) 2,3,5,4′- tetrahydroxystilbene-2-O-beta-d-glucoside (THSG) induces melanogenesis in B16 cells by MAP kinase activation and tyrosinase upregulation. Life Sci 85:345-350
13. Kim DS, Hwang ES, Lee JE, Kim SY, Kwon SB, Park KC (2003) Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation. J Cell Sci 116:1699-1706
14. Son YO, Lee SA, Kim SS, Jang YS, Chun JC, Lee JC (2011) Acteoside inhibits melanogenesis in B16F10 cells through ERK activation and tyrosinase down-regulation. J Pharm Pharmacol 63:1309-1319
15. Azhar Ul-Haq, Malik A, Khan MT, Anwar-Ul- Haq, Khan SB, Ahmad A, Choudhary MI (2006) Tyrosinase inhibitory lignans from the methanol extract of the roots of Vitex negundo Linn. and their structure-activity relationship. Phytomedicine 13:255-260
16. Tsuboi T, Kondoh H, Hiratsuka J, Mishima Y (1998) Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma. Pigment Cell Res 11:275-282
17. Tomita Y, Maeda K, Tagami H (1992) Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in post-inflammatory pigmentation. Pigment Cell Res 5:357-361
18. Gao H, Nishida J, Saito S, Kawabata J (2007) Inhibitory effects of 5,6,7-trihydroxyflavones on tyrosinase. Molecules 12:86-97
19. Busca R, Bertolotto C, Ortonne JP, Ballotti R (1996) Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem 271:31824-31830
20. Malmstrom J, Christophersen C, Barrero AF, Oltra JE, Justicia J, Rosales A (2002) Bioactive metabolites from a marine-derived strain of the fungus Emericella variecolor. J Nat Prod 65:364-367
21. Khaled M, Larribere L, Bille K, Ortonne JP, Ballotti R, Bertolotto C (2003) Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway. J Invest Dermatol 121:31-836
22. Chen CH, Song TY, Liang YC, Hu ML (2009) Acteoside and 6-O-acetylacteoside downregulate cell adhesion molecules induced by IL-1beta through inhibition of ERK and JNK in human vascular endothelial cells. J Agric Food Chem 57:8852-8859
23. Park SH, Kim DS, Kim WG, Ryoo IJ, Lee DH, Huh CH, Youn SW, Yoo ID, Park KC (2004) Terrein: a new melanogenesis inhibitor and its mechanism. Cell Mol Life Sci 61:2878-2885